SCHEMBL5225925

SCHEMBL5225925

CCCCCCCCCCCCCCCC(=O)N[C@@H](CC(=O)OCC)C(=O)OCC

nearest known ligand 0.68

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.68
POLB P06746 1/20 0.61
NOD1 Q9Y239 8/20 0.55
L3MBTL1 Q9Y468 1/20 0.53
MEN1 O00255 1/20 0.51
FAAH O00519 1/20 0.51
MAPK1 P28482 1/20 0.51
GAA P10253 1/20 0.49
DNM1 Q05193 1/20 0.46
LPAR3 Q9UBY5 2/20 0.44
HSP90AA1 P07900 1/20 0.43
PLA2G2C Q5R387 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28159360 1.00 KMT2A (0.68) KMT2APOLBNOD1L3MBTL1MEN1
SCHEMBL8019574 0.90 NOD1 (0.60) KMT2APOLBNOD1MEN1FAAH
SCHEMBL8019564 0.88 KMT2A (0.60) KMT2APOLBNOD1L3MBTL1MEN1
SCHEMBL8019568 0.88 KMT2A (0.60) KMT2APOLBNOD1L3MBTL1MEN1
SCHEMBL24095932 0.87 KMT2A (0.58) KMT2APOLBNOD1L3MBTL1MEN1
SCHEMBL28067928 0.87 NOD1 (0.56) KMT2APOLBNOD1MEN1FAAH
SCHEMBL9442141 0.87 NOD1 (0.56) KMT2APOLBNOD1MEN1FAAH
SCHEMBL31681672 0.87 KMT2A (0.91) KMT2APOLBNOD1L3MBTL1MEN1
SCHEMBL27938456 0.87 NOD1 (0.56) KMT2APOLBNOD1MEN1FAAH
SCHEMBL24411036 0.84 KMT2A (0.63) KMT2APOLBNOD1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108743548-B Cefprozil granules and preparation method thereof 苏州盛达药业有限公司 2021-08-06 CN claimed
CN-122074671-A Hu sheep active peptide complex and application thereof in bone health care 2026-05-26 CN disclosed
CN-108743548-B Cefprozil granules and preparation method thereof 苏州盛达药业有限公司 2021-08-06 CN disclosed
EP-1394161-B1 L-ASCORBIC ACID-2-O-MALEIC ACID-A-TOCOPHEROL DIESTER 1-PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME SENJU PHARMA CO (JP) 2007-04-18 EP disclosed
US-6828348-B2 Cosmetic component or ingredient, antioxidant, radical scavenger, anti-inflammatory agent or elastase inhibitor SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-12-07 US disclosed
US-20040171676-A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-09-02 US disclosed
EP-1394161-A9 L-ASCORBIC ACID-2-O-MALEIC ACID-A-TOCOPHEROL DIESTER 1-PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME Senju Pharmaceutical Co., Ltd. (JP) 2004-07-07 EP disclosed
US-20030125572-A1 Diester compounds of maleic acid (or fumaric acid) SENJU PHARMACEUTICAL CO., LTD. (JP) 2003-07-03 US disclosed
EP-1195377-A1 DIESTERS OF MALEIC OR FUMARIC ACID Senju Pharmaceutical Co., Ltd. (JP) 2002-04-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171676-A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same TTPA, SERPINB1, ELANE KMT2A 3616/4885POLB 473/4885NOD1 3310/4885
US-20030125572-A1 Diester compounds of maleic acid (or fumaric acid) MDH2, FH, ME2 KMT2A 1023/4885POLB 959/4885NOD1 2887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.